Literature DB >> 18190896

Protective effect of nitric oxide synthase inhibition or antioxidants on brain oxidative damage caused by intracerebroventricular arginine administration.

Débora Delwing1, Daniela Delwing, Caren S Bavaresco, Angela T S Wyse.   

Abstract

We have previously demonstrated that acute arginine administration induces oxidative stress and compromises energy metabolism in rat hippocampus. In the present study, we initially investigated the effect of intracerebroventricular infusion of arginine (0.1, 0.5 and 1.5 mM solution) on Na(+),K(+)-ATPase activity and on some parameters of oxidative stress, namely thiobarbituric acid-reactive substances (TBA-RS) and total radical-trapping antioxidant parameter (TRAP) in the hippocampus of rats. Results showed that 1.5 mM arginine solution significantly increases TBA-RS and reduces Na(+),K(+)-ATPase activity and TRAP in the rat hippocampus. We also evaluated the influence of the nitric oxide synthase inhibitor, N(omega)-nitro-L-arginine methyl ester (L-NAME), and antioxidants, namely alpha-tocopherol plus ascorbic acid, on the effects elicited by arginine on Na(+),K(+)-ATPase activity, TBA-RS and TRAP. Results showed that treatment with alpha-tocopherol plus ascorbic acid per se did not alter these parameters but prevented these effects. Furthermore, intracerebroventricular infusion of L-NAME prevented the inhibition caused by arginine on Na(+),K(+)-ATPase activity, as well as the increased of TBA-RS. Our findings indicate that intracerebroventricular infusion of arginine induces oxidative stress in rat hippocampus and that the inhibition of Na(+),K(+)-ATPase activity caused by this amino acid was probably mediated by NO and/or its derivatives ONOO(-) and/or other free radicals. Finally, we suggest that the administration of antioxidants should be considered as an adjuvant therapy to specific diets in hyperargininemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18190896     DOI: 10.1016/j.brainres.2007.11.052

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  D-Galactose Causes Motor Coordination Impairment, and Histological and Biochemical Changes in the Cerebellum of Rats.

Authors:  André Felipe Rodrigues; Helena Biasibetti; Bruna Stela Zanotto; Eduardo Farias Sanches; Felipe Schmitz; Vinícius Tejada Nunes; Paula Pierozan; Vanusa Manfredini; Débora Delwing Dal Magro; Carlos Alexandre Netto; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2016-06-20       Impact factor: 5.590

2.  Maternal depression model: long-lasting effects on the mother following separation from pups.

Authors:  Eduardo von Poser Toigo; Luisa A Diehl; Andréa G K Ferreira; Vanize Mackedanz; Vanize Mackendanz; Rachel Krolow; André N D Benitz; Cristie Noschang; Ana Paula Huffell; Patrícia P Silveira; Angela T S Wyse; Carla Dalmaz
Journal:  Neurochem Res       Date:  2011-09-11       Impact factor: 3.996

3.  Metabolic profiling in children with autism spectrum disorder with and without mental regression: preliminary results from a cross-sectional case-control study.

Authors:  O D Rangel-Huerta; A Gomez-Fernández; M J de la Torre-Aguilar; A Gil; J L Perez-Navero; K Flores-Rojas; P Martín-Borreguero; M Gil-Campos
Journal:  Metabolomics       Date:  2019-06-27       Impact factor: 4.290

4.  Effects of catechin on a rodent model of autism spectrum disorder: implications for the role of nitric oxide in neuroinflammatory pathway.

Authors:  Rishab Mehta; Ranjana Bhandari; Anurag Kuhad
Journal:  Psychopharmacology (Berl)       Date:  2021-08-27       Impact factor: 4.415

Review 5.  Hyperammonemia in Inherited Metabolic Diseases.

Authors:  Graziela Schmitt Ribas; Franciele Fátima Lopes; Marion Deon; Carmen Regla Vargas
Journal:  Cell Mol Neurobiol       Date:  2021-10-19       Impact factor: 4.231

6.  Protective effect of antioxidants on cerebrum oxidative damage caused by arginine on pyruvate kinase activity.

Authors:  Débora Delwing; Daniela Delwing de Lima; Bianca Scolaro; Gabriela G Kuss; José G P Cruz; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2009-08-26       Impact factor: 3.584

7.  Clinical phenotype, biochemical profile, and treatment in 19 patients with arginase 1 deficiency.

Authors:  Martina Huemer; Daniel R Carvalho; Jaime M Brum; Özlem Ünal; Turgay Coskun; James D Weisfeld-Adams; Nina L Schrager; Sabine Scholl-Bürgi; Andrea Schlune; Markus G Donner; Martin Hersberger; Claudio Gemperle; Brunhilde Riesner; Hanno Ulmer; Johannes Häberle; Daniela Karall
Journal:  J Inherit Metab Dis       Date:  2016-04-01       Impact factor: 4.982

8.  Altered metabolites in the plasma of autism spectrum disorder: a capillary electrophoresis time-of-flight mass spectroscopy study.

Authors:  Hitoshi Kuwabara; Hidenori Yamasue; Shinsuke Koike; Hideyuki Inoue; Yuki Kawakubo; Miho Kuroda; Yosuke Takano; Norichika Iwashiro; Tatsunobu Natsubori; Yuta Aoki; Yukiko Kano; Kiyoto Kasai
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

9.  Integration of Metabonomics and Transcriptomics Reveals the Therapeutic Effects and Mechanisms of Baoyuan Decoction for Myocardial Ischemia.

Authors:  Zhiyong Du; Zeliu Shu; Wei Lei; Chun Li; Kewu Zeng; Xiaoyu Guo; Mingbo Zhao; Pengfei Tu; Yong Jiang
Journal:  Front Pharmacol       Date:  2018-05-23       Impact factor: 5.810

Review 10.  Profiles of urine and blood metabolomics in autism spectrum disorders.

Authors:  Narueporn Likhitweerawong; Chanisa Thonusin; Nonglak Boonchooduang; Orawan Louthrenoo; Intawat Nookaew; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  Metab Brain Dis       Date:  2021-08-02       Impact factor: 3.655

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.